echemi logo
Product
  • Product
  • Supplier
  • Inquiry

    pak4

    Echemi shares different kinds of information about pak4. Maybe you'll get different insights into pak4 here.
    • Deqi Pharmaceuticals PAK4/NAMPT dual target inhibitor ATG-019 clinical trial application approved in China

      Time of Update: 2021-04-19
      In the future, I look forward to the launch of the first clinical trial of ATG-019 in mainland China, which will bring a new treatment option for patients with advanced solid tumors and non-Hodgkin's lymphoma.
    • Car-T therapy's new partner, PAK4 inhibitors

      Time of Update: 2021-01-03
      In a new study published November 30 in Nature Cancer, a team of researchers from Sun Yat-sen University and the University of Pennsylvania found that the absence of PAK4 in glioblastoma (GBM) endoblasts "normalizes" tumor micro-environmental blood vessels and inhibits PAK4 to improve the effectiveness of CAR-T cell therapy in GBM, both of which can significantly improve survival in mice.
    • PAK4 inhibitor, a new assistant of PD-1

      Time of Update: 2019-12-16
      Wen man dialect The success of immunotherapy such as PD-1 antibody has significantly changed the current situation of cancer treatment This new therapy, which regulates the human immune system to atta

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.